Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer

被引:3
|
作者
Baiomy, Ali [1 ]
Jensen, Corey T. [2 ]
Ward, John F. [3 ]
Chasen, Beth A. [4 ]
Ravizzini, Gregory C. [4 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Div Diagnost Imaging, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Abdominal Imaging, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, 1400 Pressler St,Unit 1483, Houston, TX 77030 USA
关键词
F-18-fluciclovine; aggressive fibromatosis; desmoid tumor; false-positive; PET/CT; ACID;
D O I
10.1097/RLU.0000000000003459
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A 74-year-old man with biochemical recurrent prostate cancer underwent 18F-fluciclovine PET/CT for restaging to determine subsequent treatment strategy. 18F-fluciclovine PET/CT imaging demonstrated incidental focal heterogeneous increased 18F-fluciclovine uptake corresponding to a soft tissue nodule within the musculature of the left anterior abdominal wall. Subsequent ultrasound-guided biopsy of the lesion revealed histopathology compatible with a desmoid tumor. Consequently, the patient underwent surgical resection with wide local excision of the lesion. © 2020 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:355 / 357
页数:3
相关论文
共 50 条
  • [31] Metastatic Male Breast Cancer With Increased Uptake on 18F-Fluciclovine PET/CT Scan
    Gill, Harkanwar S.
    Tade, Funmilayo
    Greenwald, David Theodore
    Yonover, Paul M.
    Savir-Baruch, Bital
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (01) : 23 - 24
  • [32] The Use of 18F-fluciclovine PET/CT in Prostate Cancer Diagnosis and Therapeutic Decision Making
    Dreyfuss, A.
    Ahn, G. S.
    Barsky, A. R.
    Pantel, A. R.
    Vapiwala, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E883 - E883
  • [33] 18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review
    Soroush Rais-Bahrami
    Jason A. Efstathiou
    Catriona M. Turnbull
    Stephen B. Camper
    Andy Kenwright
    David M. Schuster
    Andrew F. Scarsbrook
    Prostate Cancer and Prostatic Diseases, 2021, 24 : 997 - 1006
  • [34] 18F-Fluciclovine PET/CT Use in the Evaluation of Endometrial Cancer
    Lee, Justin
    Liotta, Margaret
    Buehner, Tina
    Potkul, Ronald
    Lovrec, Petra
    Kim, Yo Sup
    Wagner, Robert
    Savir-Baruch, Bital
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [35] 18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review
    Rais-Bahrami, Soroush
    Efstathiou, Jason A.
    Turnbull, Catriona M.
    Camper, Stephen B.
    Kenwright, Andy
    Schuster, David M.
    Scarsbrook, Andrew F.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (04) : 997 - 1006
  • [36] Pituitary Adenoma on 18F-Fluciclovine PET/CT
    Wang, Jiaqiong
    Foley, Mark
    Kuker, Russ
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (01) : E65 - E66
  • [37] 18F-Fluciclovine Uptake by an Incidentally Detected Hepatocellular Carcinoma in a Case of Biochemically Recurrent Prostate Cancer
    Sannananja, Bhagya
    Shah, Hardik Uresh
    Behnia, Fatemeh
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (09) : 692 - 693
  • [38] Incidentally Detected Oropharyngeal Squamous Cell Carcinoma on 18F-Fluciclovine PET/CT
    Raghavan, Kesav
    Wen, Kwun Wah
    Small, Eric J.
    Ha, Patrick
    Flavell, Robert R.
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (05) : E367 - E369
  • [39] The positivity rates of 18F-fluciclovine and 18F-choline PET/CT in men with recurrent prostate cancer
    Lovrec, P.
    Golubic, A.
    Huic, D.
    Wagner, R.
    Gabriel, S.
    Solanki, A.
    Gupta, G.
    Savir-Baruch, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S528 - S528
  • [40] Salvage Therapies After 18F-Fluciclovine Detected Prostate Cancer Recurrences
    Hwang, Lindsay
    Paluch, Jeremy
    Jadvar, Hossein
    England, Joseph R.
    Desai, Bhushan
    Ballas, Leslie K.
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (09) : 668 - 671